A label-free dual immunosensor for the simultaneous electrochemical determination of CA125 and HE4 biomarkers for the early diagnosis of ovarian cancer | SpringerLink
Ovarian Cancer | Proteintech Group
Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science
HE4 in ovarian and uterine cancer » Professor Andreas Obermair
Electrochemical immunomagnetic assay as biosensing strategy for determination of ovarian cancer antigen HE4 in human serum - ScienceDirect
Ovarian Cancer Tumor Markers | GeneTex
Diagnosis of ovarian epithelial cancer by performing a HE4 test
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer | PLOS ONE
Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 - ScienceDirect
Frontiers | Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer
Reference ranges of HE4 and CA125 according to age group | Download Table
Table I from The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer | Semantic Scholar
JGO :: Journal of Gynecologic Oncology
Learn About HE4 - A Biomarker of Cancers in Women - Mindray Global
Simultaneous Detection of Ovarian Cancer-Concerned HE4 and CA125 Markers Based on Cu Single-Atom-Triggered CdS QDs and Eu MOF@Isoluminol ECL | Analytical Chemistry
IJMS | Free Full-Text | Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis
HE4, A New Potential Tumor Marker for Early Diagnosis and Predicting of Breast Cancer Progression
Diagnostics | Free Full-Text | Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy
WFDC Protein: A Promising Diagnosis Biomarker of Ovarian Cancer
What is the HE4 ovarian cancer test? - Quora
OncoOVARIAN Dx – Ovarian Cancer Diagnosis Test – Bioprognos
Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer
